1LIFE HEALTHCARE, IN

ONEM
Delayed Quote. Delayed  - 10/25 04:00:00 pm
22.19USD +1.14%
Valuation
Fiscal Period: December 2020 2021
Capitalization1 5 8064 303
Entreprise Value (EV)1 5 9344 137
P/E ratio -58,2x-16,6x
Yield --
Capitalization / Revenue 15,3x7,23x
EV / Revenue 15,6x6,95x
EV / EBITDA -427x-95,4x
Price to Book 10,7x1,73x
Nbr of stocks (in thousands) 133 013193 902
Reference price (USD) 43,722,2
Announcement Date 02/25/2021-
Previous period Next period
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 380595
EBITDA1 -13,9-43,4
Operating profit (EBIT)1 -71,4-209
Operating Margin -18,8%-35,2%
Pre-Tax Profit (EBT)1 -89,5-197
Net income1 -88,7-217
Net margin -23,3%-36,4%
EPS2 -0,75-1,34
Dividend per Share2 --
Announcement Date 02/25/2021-
Previous period Next period
1 USD in Million
2 USD
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 128-
Net Cash position1 -165
Leverage (Debt / EBITDA) -9,23x3,81x
Free Cash Flow1 -68,1-23,1
ROE (Net Profit / Equities) -49,1%-18,4%
Shareholders' equity1 1811 179
ROA (Net Profit / Asset) -11,8%-11,6%
Assets1 7511 870
Book Value Per Share2 4,0812,8
Cash Flow per Share2 -0,040,45
Capex1 63,761,1
Capex / Sales 16,8%10,3%
Announcement Date 02/25/2021-
Previous period Next period
1 USD in Million
2 USD
Financial Ratios
Size 2021e 2022e
Capitalization 4 303 M $ -
Entreprise Value (EV) 4 137 M $ 4 151 M $
Valuation 2021e 2022e
P/E ratio (Price / EPS) -16,6x -15,5x
Capitalization / Revenue 7,23x 4,07x
EV / Revenue 6,95x 3,92x
EV / EBITDA -95,4x -39,0x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 1,73x 2,67x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) -35,2% -28,5%
Operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) -36,4% -26,4%
ROA (Net Profit / Asset) -11,6% -10,8%
ROE (Net Profit / Equities) -18,4% -12,5%
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   10,3% 6,13%
Cash Flow / Sales 14,7% -19,1%
Capital Intensity (Assets / Sales) 3,14x 2,44x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend